Revie ⊕: pilot study of an intervention that aims to promote the dignity of persons with advanced cancer

ISRCTN ISRCTN12497093
DOI https://doi.org/10.1186/ISRCTN12497093
Secondary identifying numbers 15-037
Submission date
04/05/2016
Registration date
13/05/2016
Last edited
14/06/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
A new life review intervention (programme) "Revie ⊕" for adults with advanced cancer has been developed. It consists of sharing significant events about a person's life history and supporting personal development by focusing on positive changes that have occurred since being diagnosed with cancer. Based on this information, a booklet is created, in which photos, poems, or another important text can be included. Once completed, the booklets are given to the participants. The focus of the intervention is to help patients approach the end-of-life in a more positive and dignified way. It can contribute to personal development and a better overall level of satisfaction with life. This study aims to evaluate the feasibility of Revie ⊕ .

Who can participate?
Adults (aged 18 or older) with advanced cancer.

What does the study involve?
The intervention involves a patient having two sessions with a nurse. In the first session (which takes one hour) the patient is asked to share significant events in their life, discuss their concerns about death and dying, their vision of life and their relationships and focus on positive changes that have occurred since the cancer diagnosis. Drawing on this information, a booklet is created. In the second session (15-30 minutes), this booklet is presented, completed, and finalized. Patients can include photos, poems, or another text that they deem important. Once completed, the booklets are given to the participants.

What are possible benefits and risks for participating?
Patients may benefit from the intervention by promoting dignity, increasing their personal development an overall life satisfaction. The risk of adverse events during the intervention is estimated to be low. Nevertheless if a distress is perceived, the person can benefit from a consultation by a psychologist.

Where is the study run from?
Geneva University Hospital (Switzerland)

When is the study starting and how long is it expected to run?
August 2013 to January 2017

Who is funding the study?
HES-SO University of Applied Sciences and Arts Western Switzerland, School of Health Sciences, Geneva (Switzerland)

Who is the main contact?
Maria Goreti da Rocha Rodrigues

Contact information

Mrs Maria Goreti da Rocha Rodrigues
Scientific

47 Avenue de Champel
Geneva
1206
Switzerland

ORCiD logoORCID ID 0000-0001-7136-8345
Dr Maya Shaha
Scientific

Rue de la Corniche 10
Lausanne
1010
Switzerland

Dr Sophie Pautex
Scientific

4, rue Gabrielle-Perret-Gentil
Geneva
1211
Switzerland

Study information

Study designPilot pre-post feasibility study using a mixed method approach, i.e. an embedded concurrent design with both quantitative and qualitative parts.
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet ISRCTN12497093_PIS_French.docx
Scientific titleRevie ⊕: the influence of a life review intervention including a positive, patient-centered approach towards enhancing the personal dignity of patients with advanced cancer. A study protocol for a feasibility study using a mixed method investigation
Study acronymRevie ⊕
Study objectivesTo evaluate the feasibility and preliminary efficacy of a novel intervention, Revie ⊕, to promote the dignity of patients with advanced cancer
Ethics approval(s)Swiss Ethics Committees on research involving humans, Geneva, 04/06/2015, ref: 15-037
Health condition(s) or problem(s) studiedAdvanced cancer patients, palliative care
InterventionLife review intervention using a patient-centered positive approach. The intervention encompasses two sessions between a nurse and a patient. In the first session (60 minutes) the participant is firstly asked to share significant events in his life and secondly personal development is supported by focusing on positive changes that have occurred since the cancer diagnosis. In this first intervention five domains are addressed, namely:

1. Reflecting on the patient's life story and specific significant events;
2. Focusing on the positive changes that have occurred since the disease diagnosis;
3. Patients telling their values and vision of life and their relationship with others;
4. Discussing significant issues,
5. Discussing the patient’s deepest concerns and their thoughts about death and dying.

Drawing on this information, a booklet is created. In the second session (15-30 minutes), this booklet is presented, completed, and finalized. Patients can include photos, poems, or another text that they deem important. Once completed, the booklets are given to the participants.
Intervention typeBehavioural
Primary outcome measure1. Number of participants recruited: timepoint: end of recruitment: May 2016
2. Intervention retention rates. timepoint: end of recruitment: May 2016
3. Acceptability of the intervention for patients: semi-directed interview about the process and questionnaire about acceptability (T2 post- intervention)
4. Acceptability for nurses delivering the intervention in terms of fidelity (adherence structured content), resources mobilized, and practice change. Diary , focus group and questionnaire end of recruitment: May 2016
Secondary outcome measures1. Sense of dignity, with The Patient Dignity Inventory (PDI) questionnaire (T0 baseline + T2 post intervention)
2. Post traumatic growth, with The Post-Traumatic Growth Inventory (PTGI) (T0 baseline + T2 post intervention)
3. Satisfaction with life, with The Satisfaction with Life Scale (SWLS) (T0 baseline + T2 post intervention)
Overall study start date31/08/2013
Completion date30/01/2017

Eligibility

Participant type(s)Mixed
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsN=40
Key inclusion criteria1. Adults (aged 18 years or older) with advanced cancer (T3 or T4, or the presence of metastases)
2. Adequate health status to participate in the study, as determined by clinical consensus between nurses and physicians
3. Able to cognitively understand
4. Consent to inclusion in the study
Key exclusion criteria1. Patients diagnosed with cognitive disorders related to memory loss or disturbances of speech that would not allow for a constructive exchange,
2. with insufficient command of the French language to complete the study questionnaires.
Date of first enrolment15/04/2015
Date of final enrolment30/04/2016

Locations

Countries of recruitment

  • Switzerland

Study participating centre

University Hospital Geneva (Hôpital Universitaire de Genève)
Geneva
122 Genève 14
Switzerland

Sponsor information

University Institute of Training and Care Research (IUFRS) (Institut Universitaire de Formation et de Recherche en Soins)
University/education

Biopôle 2
Route de la Corniche 10
Lausanne
1010
Switzerland

Phone +41 21 314 58 15
Email iufrs@unil.ch
Website https://www.unil.ch/sciences-infirmieres/fr/home/menuinst/iufrs.html
ROR logo "ROR" https://ror.org/029ma5383

Funders

Funder type

University/education

HES-SO University of Applied Sciences and Arts Western Switzerland, School of Health Sciences, Geneva, Switzerland

No information available

Results and Publications

Intention to publish date30/11/2016
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryStored in repository
Publication and dissemination plan1. March 2016: submitted to be published in the journal Pilot and Feasibility Studies. : “Revie + The influence of a life review intervention including a positive, patient-centered approach towards enhancing the personal dignity of patients with advanced cancer. A study protocol for a feasibility study using a mixed method investigation”
2. September 2016: manuscript on the development of the intervention and link with the theoretical framework
3. November 2016: a manuscript on the results of the study
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet 25/05/2016 No Yes
Protocol article protocol 01/12/2016 Yes No
Abstract results S6 27/07/2017 14/06/2023 No No

Additional files

ISRCTN12497093_PIS_French.docx
uploaded 25/05/2016

Editorial Notes

14/06/2023: Publication reference added.
08/11/2016: Publication reference added.
25/05/2016: Uploaded participant information sheet.